Rep. Jared Moskowitz Buys Cencora, Inc. (NYSE:COR) Stock

Representative Jared Moskowitz (Democratic-Florida) recently bought shares of Cencora, Inc. (NYSE:COR). In a filing disclosed on April 30th, the Representative disclosed that they had bought between $1,001 and $15,000 in Cencora stock on March 31st. The trade occurred in the Representative’s “MORGAN STANLEY ACTIVE ASSETS (1)” account.

Representative Jared Moskowitz also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Caterpillar (NYSE:CAT) on 3/31/2026.
• Purchased $1,001 – $15,000 in shares of Palo Alto Networks (NASDAQ:PANW) on 3/31/2026.
• Purchased $1,001 – $15,000 in shares of McDonald’s (NYSE:MCD) on 3/31/2026.
• Purchased $1,001 – $15,000 in shares of GE Aerospace (NYSE:GE) on 3/31/2026.
• Sold $15,001 – $50,000 in shares of Qualcomm (NASDAQ:QCOM) on 3/31/2026.
• Purchased $1,001 – $15,000 in shares of American Express (NYSE:AXP) on 3/31/2026.
• Purchased $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 3/31/2026.
• Purchased $1,001 – $15,000 in shares of Chubb (NYSE:CB) on 3/31/2026.
• Sold $1,001 – $15,000 in shares of Cummins (NYSE:CMI) on 3/31/2026.
• Purchased $1,001 – $15,000 in shares of General Dynamics (NYSE:GD) on 3/31/2026.

Cencora Price Performance

Shares of NYSE COR opened at $304.18 on Friday. Cencora, Inc. has a twelve month low of $271.00 and a twelve month high of $377.54. The firm has a market cap of $59.17 billion, a P/E ratio of 36.56, a PEG ratio of 1.44 and a beta of 0.65. The company has a 50 day moving average of $333.36 and a 200 day moving average of $342.95. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62.

Cencora (NYSE:COR) last issued its earnings results on Wednesday, February 4th. The company reported $4.08 EPS for the quarter, beating the consensus estimate of $4.04 by $0.04. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The business had revenue of $85.93 billion for the quarter, compared to the consensus estimate of $86.12 billion. During the same period last year, the business posted $3.73 EPS. The company’s revenue was up 5.5% compared to the same quarter last year. As a group, research analysts expect that Cencora, Inc. will post 17.56 EPS for the current fiscal year.

Cencora Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Shareholders of record on Friday, February 13th were issued a $0.60 dividend. The ex-dividend date of this dividend was Friday, February 13th. This represents a $2.40 annualized dividend and a yield of 0.8%. Cencora’s payout ratio is 28.85%.

Institutional Trading of Cencora

Several large investors have recently modified their holdings of the company. Kemnay Advisory Services Inc. purchased a new position in Cencora in the fourth quarter worth about $25,000. Oakworth Capital Inc. purchased a new stake in shares of Cencora during the 4th quarter valued at about $26,000. Elyxium Wealth LLC bought a new position in shares of Cencora in the 4th quarter worth approximately $27,000. Archer Investment Corp boosted its holdings in shares of Cencora by 134.3% in the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after buying an additional 47 shares during the last quarter. Finally, Motiv8 Investments LLC purchased a new position in shares of Cencora in the fourth quarter worth approximately $29,000. Institutional investors own 97.52% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently commented on COR shares. Leerink Partners reiterated an “outperform” rating on shares of Cencora in a report on Tuesday, March 17th. Evercore set a $360.00 target price on shares of Cencora in a research note on Wednesday, April 8th. Barclays raised their price target on shares of Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a report on Friday, February 13th. JPMorgan Chase & Co. lifted their price target on shares of Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Finally, Robert W. Baird set a $415.00 price objective on shares of Cencora in a report on Tuesday, January 13th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cencora currently has a consensus rating of “Moderate Buy” and a consensus target price of $398.17.

About Representative Moskowitz

Jared Evan Moskowitz (Democratic Party) is a member of the U.S. House, representing Florida’s 23rd Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Moskowitz (Democratic Party) is running for re-election to the U.S. House to represent Florida’s 23rd Congressional District. He declared candidacy for the 2026 election.

Jared Evan Moskowitz was born in Coral Springs, Florida. Moskowitz graduated from Marjory Stoneman Douglas High School. He earned a bachelor’s degree in political science and government from George Washington University in 2003 and a law degree from Nova Southeastern University in 2007. Moskowitz’s career experience includes working as the director of the Florida Division of Emergency Management and general counsel with AshBritt Inc.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.